Sundrug Co.,Ltd. (TYO:9989)

Sundrug Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	442,195	457,403	492,316	545,814	425,016	347,847
Market Cap Growth	-15.20%	-7.09%	-9.80%	28.42%	22.18%	-26.53%
Enterprise Value	419,887	436,344	465,731	478,562	340,191	259,171
Last Close Price	3780.00	3910.00	4077.92	4386.36	3329.99	2649.22

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	14.09	14.57	16.01	18.74	16.54	14.58
Forward PE	13.09	13.44	15.39	18.06	16.01	13.16
PS Ratio	0.52	0.54	0.61	0.73	0.62	0.54
PB Ratio	1.55	1.60	1.83	2.16	1.80	1.58
P/TBV Ratio	1.59	1.65	1.89	2.24	1.87	1.62
P/FCF Ratio	34.12	35.29	63.83	114.62	33.76	27.06
P/OCF Ratio	10.21	10.56	11.96	13.25	11.37	10.98
PEG Ratio	2.09	2.33	3.14	2.39	2.41	2.68

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.50	0.52	0.58	0.64	0.49	0.40
EV/EBITDA Ratio	6.53	6.65	7.54	8.53	6.87	5.86
EV/EBIT Ratio	9.21	9.32	10.47	11.67	9.08	7.61
EV/FCF Ratio	32.40	33.67	60.38	100.50	27.02	20.16

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.17	0.17	0.14	0.14	-	-
Debt / EBITDA Ratio	0.74	0.74	0.63	0.62	-	-
Debt / FCF Ratio	3.72	3.72	5.01	7.35	-	-
Net Debt / Equity Ratio	-0.08	-0.08	-0.10	-0.14	-0.34	-0.40
Net Debt / EBITDA Ratio	-0.34	-0.34	-0.43	-0.62	-1.63	-2.02
Net Debt / FCF Ratio	-1.72	-1.72	-3.41	-7.29	-6.42	-6.95
Asset Turnover	1.83	1.83	1.86	1.93	2.01	2.05
Inventory Turnover	5.99	5.99	6.29	6.45	6.67	6.79
Quick Ratio	0.91	0.91	0.88	0.72	1.05	1.28
Current Ratio	1.78	1.78	1.69	1.34	1.82	2.08
Return on Equity (ROE)	11.30%	11.30%	11.76%	11.90%	11.25%	11.21%
Return on Assets (ROA)	6.37%	6.37%	6.44%	6.56%	6.82%	6.71%
Return on Invested Capital (ROIC)	12.31%	12.66%	13.60%	15.48%	17.81%	18.75%
Return on Capital Employed (ROCE)	13.70%	13.70%	14.10%	15.50%	15.10%	14.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	7.10%	6.86%	6.25%	5.34%	6.05%	6.86%
FCF Yield	2.93%	2.83%	1.57%	0.87%	2.96%	3.70%
Dividend Yield	3.49%	3.35%	3.19%	2.60%	3.00%	2.68%
Payout Ratio	48.43%	48.43%	46.39%	42.95%	39.11%	34.32%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.02%	-0.01%	-0.01%	-0.00%
Total Shareholder Return	3.48%	3.34%	3.17%	2.59%	3.00%	2.68%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error